ProQR Therapeutics PRQR
NASDAQ PRQR
$1.63 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

ProQR Therapeutics (PRQR) Depreciation and Depletion (2013 - 2026)

Updated

ProQR Therapeutics (PRQR) recorded Depreciation and Depletion of $821,790 in the quarter ended Jun 30, 2026, up 7.6% from $764,073 a year earlier and up 1.1% from the prior quarter.

Analysis

ProQR Therapeutics (PRQR) Depreciation and Depletion (2013 - 2026) Analysis & Trends

On a TTM basis, ProQR Therapeutics' Depreciation and Depletion came in at $3.21 million as of Jun 30, 2026, up 8.8% year-over-year; for the year ended Dec 31, 2025, it came in at $3.05 million, up 2.2% from the prior year.

  • Annual Depreciation and Depletion has increased for three straight years, with a five-year compound annual growth rate of 2.6% (years ended Dec 2020 to Dec 2025).
  • Across earlier years, Depreciation and Depletion came in at $2.99 million in the year ended Dec 31, 2024 (+9.9%), $2.72 million in the year ended Dec 31, 2023 (+2.3%), $2.66 million in the year ended Dec 31, 2022 (-3.6%) and $2.76 million in the year ended Dec 31, 2021 (+2.5%).
  • The figure for the quarter ended Jun 30, 2026 is the highest quarterly Depreciation and Depletion since the quarter ended Jun 30, 2018.
  • On a year-over-year basis, Depreciation and Depletion has increased for four consecutive quarters, with growth averaging 3.7% over the last eight quarters.
  • Peak year-over-year performance for Depreciation and Depletion in the last five years was growth of 27.4% in the quarter ended Mar 31, 2024, against a decline of 18.8% in the quarter ended Dec 31, 2021 at the low end.
  • Per Business Quant, the preceding three quarters came in at $812,497 (quarter ended Mar 31, 2026), $790,386 (quarter ended Dec 31, 2025) and $784,436 (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Depletion (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 194.00 Mn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 98.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 ProQR Therapeutics 171.74 Mn -291.86 Mn - 821,789.83
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 821,789.83
Mar 31, 2026 812,497.48
Dec 31, 2025 790,385.55
Sep 30, 2025 784,435.97
Jun 30, 2025 764,072.79
Mar 31, 2025 713,177.65
Dec 31, 2024 717,027.51
Sep 30, 2024 755,575.02
Jun 30, 2024 765,667.07
Mar 31, 2024 750,675.98
Dec 31, 2023 783,284.25
Sep 30, 2023 698,875.09
Jun 30, 2023 646,821.09
Mar 31, 2023 589,264.66
Dec 31, 2022 763,145.03
Sep 30, 2022 617,063.89
Jun 30, 2022 630,630.50
Mar 31, 2022 639,732.50
Dec 31, 2021 631,471.97
Sep 30, 2021 641,532.30
API Access

ProQR Therapeutics Depreciation and Depletion API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=PRQR&period=max&api_key=YOUR_API_KEY